QQ客服 官方微博 反馈留言

浏览/检索结果: 共24条，第1-10条 帮助 限定条件 发表日期：2017    专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs) 会议论文 作者:  Soo, R.;  Mok, T. S. K.;  Shi, Y-K.;  Zhang, L.;  Lu, S. 收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05 Randomized Controlled Study Comparing Adjuvant versus Neo-Adjuvant Chemotherapy in Resectable Stage IB to IIIA NSCLC 会议论文 作者:  Wu, Yi Long;  Yang, Xue-Ning;  Zhong, Wen-Zhao;  Ben, Xiao-Song;  Luo, Hong-He 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 ADJUVANT  non-small cell lung cancer  neoadjuvant  chemotherapy   A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutation. 会议论文 作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Selective lymph node dissection in early-stage non-small cell lung cancer 期刊论文 JOURNAL OF THORACIC DISEASE, 2017, 卷号: 9, 期号: 7 作者:  Han, Han;  Chen, Haiquan 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Non-small cell lung cancer (NSCLC)  lymph node dissection  minimally invasive surgery   Is a clinical target volume (CTV) necessary for locally advanced non-small cell lung cancer treated with intensity-modulated radiotherapy? -a dosimetric evaluation of three different treatment plans 期刊论文 JOURNAL OF THORACIC DISEASE, 2017, 卷号: 9, 期号: 12 作者:  Xia, Fan;  Zhou, Lijun;  Yang, Xi;  Chu, Li;  Zhang, Xiaofei 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05 Clinical target volume (CTV)  intensity-modulated radiotherapy (IMRT)  dosimetry  non-small cell lung cancer (NSCLC)   Ge tinib (G) versus vinorelbine+cisplatin (VP) as adjuvant treatment in stage IIIIIA (N1-N2) non-small-cell lung cancer (NSCLC) with EGFR-activating mutation (ADJUVANT): A randomized, Phase III trial (CTONG 1104) 期刊论文 Journal of Clinical Oncology, 2017, 卷号: 35 作者:  null 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 50 作者:  Xing, Puyuan;  Zhu, Yixiang;  Shan, Ling;  Chen, Sipeng;  Hao, Xuezhi 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 advanced non-small cell lung cancer (NSCLC)  multiple treatments  taxane  nanoparticle albumin bound paclitaxel (Nab-PTX)  secreted protein acidic and rich in cysteine (SPARC)   Long noncoding RNA GAS5 suppresses tumorigenesis by inhibiting miR-23a expression in non-small cell lung cancer 期刊论文 Oncology Research, 2017, 卷号: 25, 期号: 6 作者:  Mei, Yongcheng/57194697335[0];  Si, Jinchun/57194707801[1];  Wang, Yun/57192818516[2];  Huang, Zhuangshi/37097276200[3];  Zhu, Haiwen/57194695628[4] 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 Apoptosis  GAS5  Invasion  Long noncoding RNA (lncRNA)  MiR-23a  Non-small cell lung cancer (NSCLC)  Proliferation   MicroRNA-107-5p suppresses non-small cell lung cancer by directly targeting oncogene epidermal growth factor receptor 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 34 作者:  Wang, Ping;  Liu, Xiaomin;  Shao, Yang;  Wang, Huimin;  Liang, Chen 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 MicroRNA-107-5p  EGFR  NSCLC  tumorigenesis  proliferation   Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancer 期刊论文 JOURNAL OF THORACIC DISEASE, 2017, 卷号: 9, 期号: 8 作者:  Pan, Yunjian;  Zheng, Difan;  Li, Yuan;  Cai, Xu;  Zheng, Zongli 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Programmed death ligand 1 expression (PD-L1 expression)  non-small cell lung cancer (NSCLC)  survival